CMV & AMR in Transplant: A Focus on Graft Loss and Therapeutic Innovations

This educational activity is based on the proceedings of a symposium at the 2018 American Transplant Congress. Drs. Deepali Kumar and Alexandre Loupy present new data and challenging clinical cases in cytomegalovirus (CMV) and antibody-mediated rejection (AMR) in transplantation. You will have an opportunity to assess your skills in CMV and AMR and compare your responses to your peers when you answer interactive questions throughout the activity.

 

New Trends in Early Recognition of CDI and CMV in HSCT: A Care Team Forum^SM

This panel discussion is designed to increase your knowledge in recognizing risk for, and understanding the burden of, cytomegalovirus (CMV) and Clostridium difficile infection (CDI) in hematopoietic stem cell transplantation (HSCT) patients. Underpinned by evidence-based medicine, this activity will address challenges commonly faced in daily clinical care.

 

Prevention and Management of CDI and CMV in HSCT: A Care Team Forum^SM

This activity features a panel discussion and is designed to increase your skills in providing individualized care to your patients who have had a hematopoietic stem cell transplantation (HSCT) and are at risk for cytomegalovirus (CMV) and Clostridium difficile infection (CDI). Aided by clinical commentary, this activity will address challenges commonly faced in daily clinical care.

Personalized Therapy for Patients with Antibody-Mediated Rejection

September 17, 2019
Copenhagen, Denmark